Meeting
2020 ASCO Virtual Scientific Program
Real-world patterns of treatment and recurrence by frailty status among older women with HR-positive, HER2-negative early breast cancer.
Authors
Gregory Sampang Calip
University of Illinois at Chicago, College of Pharmacy, Chicago, IL
Gregory Sampang Calip , Colin Hubbard , Nadia Azmi Nabulsi , Alemseged Ayele Asfaw , Inyoung Lee , Jifang Zhou , Jenilee Cueto , Debanjali Mitra , Ernest H Law
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Breast Cancer—Local/Regional/Adjuvant
Track
Breast Cancer
Sub Track
Adjuvant Therapy
Citation
J Clin Oncol 38: 2020 (suppl; abstr 535)
DOI
10.1200/JCO.2020.38.15_suppl.535
Abstract #
535
Poster Bd #
27
Abstract Disclosures
Similar Posters
Poster
2023 ASCO Annual Meeting
Correlation between Oncotype DX, Predict, and Nottingham Prognostic Index on HR+, HER2- early breast cancer treatment: The current value of molecular testing.
First Author: Leticia Campoverde
Poster
2023 ASCO Annual Meeting
Outcomes in premenopausal patients with HR+/HER2- breast cancer and lymph node micro-metastasis based on the 21-gene recurrence score.
First Author: Nadeem Bilani
Poster
2023 ASCO Annual Meeting
Understanding treatment toxicity patterns through remote symptom monitoring and examining the effect of frailty in older men with metastatic prostate cancer.
First Author: Milothy Parthipan
Poster
2023 ASCO Annual Meeting
State-of-the-art management of HER2-negative early breast cancer: Treatment patterns among healthcare professionals and concordance with expert recommendations.
First Author: Marie N. Becker